Concepts (51)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Head and Neck Neoplasms | 7 | 2014 | 151 | 0.200 |
Why?
|
| Parotid Gland | 1 | 2014 | 18 | 0.110 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2014 | 38 | 0.110 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 91 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 6 | 1994 | 244 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 1994 | 176 | 0.050 |
Why?
|
| Combined Modality Therapy | 5 | 2014 | 308 | 0.040 |
Why?
|
| Common Bile Duct Diseases | 1 | 1996 | 1 | 0.030 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 1996 | 3 | 0.030 |
Why?
|
| Multiple Myeloma | 1 | 1996 | 21 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 1 | 1996 | 97 | 0.030 |
Why?
|
| Survival Rate | 1 | 2014 | 356 | 0.030 |
Why?
|
| Middle Aged | 8 | 2014 | 9320 | 0.020 |
Why?
|
| Methotrexate | 3 | 1986 | 36 | 0.020 |
Why?
|
| Female | 8 | 2014 | 15818 | 0.020 |
Why?
|
| Male | 8 | 2014 | 15399 | 0.020 |
Why?
|
| Aged | 4 | 2014 | 9343 | 0.020 |
Why?
|
| Fluorouracil | 3 | 1994 | 46 | 0.020 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 1985 | 3 | 0.020 |
Why?
|
| Vincristine | 1 | 1985 | 21 | 0.020 |
Why?
|
| Cisplatin | 3 | 1994 | 53 | 0.020 |
Why?
|
| Muscular Atrophy | 1 | 1985 | 9 | 0.020 |
Why?
|
| Humans | 9 | 2014 | 28548 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1985 | 121 | 0.010 |
Why?
|
| Leucovorin | 3 | 1986 | 9 | 0.010 |
Why?
|
| Random Allocation | 3 | 1986 | 130 | 0.010 |
Why?
|
| Neoplasm Staging | 3 | 1986 | 372 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1986 | 934 | 0.010 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1996 | 10 | 0.010 |
Why?
|
| Neoplasm Metastasis | 2 | 1985 | 102 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1994 | 53 | 0.010 |
Why?
|
| Radiotherapy | 1 | 1994 | 34 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 1994 | 81 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1994 | 267 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1994 | 270 | 0.010 |
Why?
|
| Prognosis | 2 | 1985 | 827 | 0.010 |
Why?
|
| Time Factors | 1 | 1994 | 1497 | 0.010 |
Why?
|
| Actuarial Analysis | 1 | 1989 | 8 | 0.010 |
Why?
|
| Adult | 2 | 1994 | 8172 | 0.000 |
Why?
|
| Pilot Projects | 1 | 1989 | 438 | 0.000 |
Why?
|
| Blood Transfusion | 1 | 1986 | 67 | 0.000 |
Why?
|
| Radiotherapy, High-Energy | 1 | 1985 | 4 | 0.000 |
Why?
|
| Brachytherapy | 1 | 1985 | 56 | 0.000 |
Why?
|
| Infusions, Parenteral | 1 | 1984 | 9 | 0.000 |
Why?
|
| Injections, Intramuscular | 1 | 1984 | 7 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 1994 | 3622 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1984 | 166 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1985 | 206 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1985 | 239 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1989 | 4901 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1986 | 3615 | 0.000 |
Why?
|